Real-Life Experience of a Brief Arsenic Trioxide-Based Consolidation Chemotherapy in the Management of Acute Promyelocytic Leukemia: Favorable Outcomes With Limited Anthracycline Exposure and Shorter Consolidation Therapy

Arsenic trioxide (ATO)-based consolidation chemotherapy can be effective in patients with high-risk acute promyelocytic leukemia (APL) and might reduce anthracycline-related toxicity. We report a retrospective analysis of 63 patients with APL given 1 cycle of ATO-based consolidation chemotherapy. Th...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Clin Lymphoma Myeloma Leuk
Prif Awduron: Leech, Mindy, Morris, Lawrence, Stewart, Moishe, Smith, B. Douglas, Bashey, Asad, Holland, Kent, Solomon, Scott, Zhang, Xu, Carraway, Hetty E., Pratz, Keith, Gore, Steven D., Zeidan, Amer M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2014
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4409502/
https://ncbi.nlm.nih.gov/pubmed/25499624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2014.11.001
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg